Back to RAYMOND JAMES FINANCIAL INC RAYMOND JAMES FINANCIAL INC

EPRXEPRX
7 quarters

Position history for RAYMOND JAMES FINANCIAL INCRAYMOND JAMES FINANCIAL INC's holdings in EUPRAXIA PHARMACEUTICALS INC

RAYMOND JAMES FINANCIAL INC holds 53,503 shares of EPRX (EUPRAXIA PHARMACEUTICALS INC), worth $353,655 as of 2026-Q2. The position was increased (+5.8% shares). EPRX represents 0.0% of RAYMOND JAMES FINANCIAL INC's portfolio.

Current Value

$353,655

Current Shares

53,503

Total Value Change

+$316,842

Total Shares Change

+41,890

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
53,503
+5.8%
$353,6550.0%$6.61
25
2026-Q1
Decreased
50,560
-4.5%
$366,0550.0%$8.02
0
2025-Q4
Increased
52,972
+58.7%
$399,9390.0%$7.59
34
2025-Q3
Increased
33,373
+173.3%
$196,9010.0%$5.75
37
2025-Q2
Increased
12,212
+9.7%
$70,3410.0%$5.30
16
2025-Q1
Decreased
11,133
-4.1%
$36,5170.0%$3.38
0
2024-Q4
New
11,613
-
$36,8130.0%$3.09
31

Other major holders of EPRX: BALYASNY ASSET MANAGEMENT L.P., SCOTIA CAPITAL INC.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used